CFO AND TREASURER · UNITED THERAPEUTICS Corp · Common Stock
Side
SELL
Value
$693K
Shares
1,210
Price
$572.96
Executed
Apr 13, 2026
Disclosed
Apr 14, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 13 executedApr 14, 2026 disclosed
UTHR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 8 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Edgemond James filed this Form 4 reporting a open-market sale of UTHR on Apr 13, 2026. It became public on Apr 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CFO AND TREASURER
Edgemond Jamescik:0001636178
Issuer
UNITED THERAPEUTICS Corpcik:0001082554
Revision history · 0
No field has changed since this record was first ingested.
